Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. (OLMA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · OLMA · as of Sep 30, 2025
Ownership Breakdown
131
Institutional Holders
▲ 9 vs Q2
$668.29M
Total Inst. Value
▲ $367.79M vs Q2
87.35M
Shares Outstanding
freeFloat 85.93%
68.30M
13F Shares Held
▼ 2.23M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
OLMA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC pharmaceutical preparations | 6.84M | 8.00% | 8.00% | $67.00B | Nov 14, 2025 | — held |
PARADIGM BIOCAPITAL ADVISORS LP pharmaceutical preparations | 6.79M | 7.95% | 7.95% | $66.51B | Nov 14, 2025 | ▲ 30.0K |
BVF INC/IL pharmaceutical preparations | 5.30M | 6.19% | 6.19% | $51.85B | Nov 14, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 4.73M | 5.53% | 5.53% | $46.27B | Nov 12, 2025 | ▲ 121.3K |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 3.59M | 4.19% | 4.19% | $35.09B | Nov 14, 2025 | ▲ 563.1K |
DEEP TRACK CAPITAL, LP pharmaceutical preparations | 3.47M | 4.06% | 4.06% | $33.97B | Nov 14, 2025 | ▲ 27.3K |
LOGOS GLOBAL MANAGEMENT LP pharmaceutical preparations | 3.21M | 3.75% | 3.75% | $31.41B | Nov 14, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 3.20M | 3.74% | 3.74% | $31.30B | Nov 7, 2025 | ▼ 69.7K |
FRANKLIN RESOURCES INC pharmaceutical preparations | 3.01M | 3.52% | 3.52% | $29.49B | Nov 13, 2025 | — held |
WOODLINE PARTNERS LP pharmaceutical preparations | 2.22M | 2.59% | 2.59% | $21.71B | Nov 14, 2025 | ▼ 1.29M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
21
Increased
+2.99M shares5
New Positions
first time holders17
Decreased
−3.86M shares0
Sold Out
fully exitedNet shares change (top 50)
865.6K
+2.99M / −3.86M
Net new holders
+9
5 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
OLMA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Raman Prakash director | Apr 28, 2026 | Award | 24,150 | $14.59 | $352.3K | 24.1K | Form 4 ↗ |
Raman Prakash director | Apr 28, 2026 | Award | 2,911 | $14.59 | $42.5K | 2.9K | Form 4 ↗ |
Mitchell Shawnte CHIEF LEGAL OFFICER | Mar 4, 2026 | Sale | 24,767 | $24.25 | $600.6K | 233 | Form 4 ↗ |
Mitchell Shawnte CHIEF LEGAL OFFICER | Mar 3, 2026 | Sale | 15,000 | $23.01 | $345.1K | 0 | Form 4 ↗ |
Mitchell Shawnte CHIEF LEGAL OFFICER | Mar 4, 2026 | Sale | 233 | $24.69 | $5.8K | 0 | Form 4 ↗ |
Austin Sasha Lu VP of Finance and Controller | Feb 2, 2026 | Award | 29,250 | $25.65 | $750.3K | 29.3K | Form 4 ↗ |
Austin Sasha Lu VP of Finance and Controller | Feb 2, 2026 | Award | 11,700 | — | — | 16.2K | Form 4 ↗ |
Zojwalla Naseem CHIEF MEDICAL OFFICER | Feb 2, 2026 | Award | 250,000 | $25.65 | $6.41M | 250.0K | Form 4 ↗ |
Zojwalla Naseem CHIEF MEDICAL OFFICER | Feb 2, 2026 | Award | 106,250 | $25.65 | $2.73M | 106.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Olema Pharmaceuticals, Inc. (OLMA) is primarily owned by institutional investors, who hold approximately 78.2% of total shares outstanding. Company insiders own approximately 14.07%, while retail and public investors account for the remaining 7.74%.
The largest institutional shareholder of Olema Pharmaceuticals, Inc. is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, holding approximately 6.84 million shares — equal to 8.00% of outstanding shares — as of September 30, 2025.
A total of 131 institutional investors currently hold OLMA stock, with a combined institutional value of approximately $668,290,451 as of the most recent 13F filing period.
Frequently asked questions
OLMA ownershipOlema Pharmaceuticals, Inc. (OLMA) is primarily owned by institutional investors, who hold approximately 78.2% of shares. The largest shareholder is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with a 8.00% stake. Company insiders hold 14.07%. Data sourced from SEC Form 13F as of September 30, 2025.